Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Kuros Annual Report, 2023
English version
Press Release, 8 March 2024
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Presentation at CG 2024 Musculoskeletal Conference
12 Feb 2024
Press Release, 1 February 2024
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Press Release, 31 January 2024
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Press Release, 4 January 2024
Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA